Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma.

Hara H, Takahashi T, Serada S, Fujimoto M, Ohkawara T, Nakatsuka R, Harada E, Nishigaki T, Takahashi Y, Nojima S, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Miyata H, Nakajima K, Takiguchi S, Morii E, Mori M, Doki Y, Naka T.

Br J Cancer. 2016 Jun 28;115(1):66-75. doi: 10.1038/bjc.2016.183.

PMID:
27310703
2.

Enzymatic remodeling of heparan sulfate: a therapeutic strategy for systemic and localized amyloidoses?

Nishitsuji K, Saito H, Uchimura K.

Neural Regen Res. 2016 Mar;11(3):408-9. doi: 10.4103/1673-5374.179043. No abstract available.

3.

Cellular interaction and cytotoxicity of the iowa mutation of apolipoprotein A-I (ApoA-IIowa) amyloid mediated by sulfate moieties of heparan sulfate.

Kuwabara K, Nishitsuji K, Uchimura K, Hung SC, Mizuguchi M, Nakajima H, Mikawa S, Kobayashi N, Saito H, Sakashita N.

J Biol Chem. 2015 Oct 2;290(40):24210-21. doi: 10.1074/jbc.M115.652545.

4.

Oligosaccharide substrate preferences of human extracellular sulfatase Sulf2 using liquid chromatography-mass spectrometry based glycomics approaches.

Huang Y, Mao Y, Buczek-Thomas JA, Nugent MA, Zaia J.

PLoS One. 2014 Aug 15;9(8):e105143. doi: 10.1371/journal.pone.0105143.

5.
6.

Heparan sulfate signaling in cancer.

Knelson EH, Nee JC, Blobe GC.

Trends Biochem Sci. 2014 Jun;39(6):277-88. doi: 10.1016/j.tibs.2014.03.001. Review.

7.

Post-Synthetic Regulation of HS Structure: The Yin and Yang of the Sulfs in Cancer.

Vivès RR, Seffouh A, Lortat-Jacob H.

Front Oncol. 2014 Jan 14;3:331. doi: 10.3389/fonc.2013.00331. Review.

8.

Heparan sulfate: a ubiquitous glycosaminoglycan with multiple roles in immunity.

Simon Davis DA, Parish CR.

Front Immunol. 2013 Dec 18;4:470. doi: 10.3389/fimmu.2013.00470.

9.

The SULFs, extracellular sulfatases for heparan sulfate, promote the migration of corneal epithelial cells during wound repair.

Maltseva I, Chan M, Kalus I, Dierks T, Rosen SD.

PLoS One. 2013 Aug 8;8(8):e69642. doi: 10.1371/journal.pone.0069642.

10.

Endosulfatases SULF1 and SULF2 limit Chlamydia muridarum infection.

Kim JH, Chan C, Elwell C, Singer MS, Dierks T, Lemjabbar-Alaoui H, Rosen SD, Engel JN.

Cell Microbiol. 2013 Sep;15(9):1560-71. doi: 10.1111/cmi.12133.

11.

Proteoglycans and their roles in brain cancer.

Wade A, Robinson AE, Engler JR, Petritsch C, James CD, Phillips JJ.

FEBS J. 2013 May;280(10):2399-417. doi: 10.1111/febs.12109. Review.

12.

Distinct expression patterns of Sulf1 and Hs6st1 spatially regulate heparan sulfate sulfation during prostate development.

Buresh-Stiemke RA, Malinowski RL, Keil KP, Vezina CM, Oosterhof A, Van Kuppevelt TH, Marker PC.

Dev Dyn. 2012 Dec;241(12):2005-13. doi: 10.1002/dvdy.23886.

13.
14.

Organ-specific sulfation patterns of heparan sulfate generated by extracellular sulfatases Sulf1 and Sulf2 in mice.

Nagamine S, Tamba M, Ishimine H, Araki K, Shiomi K, Okada T, Ohto T, Kunita S, Takahashi S, Wismans RG, van Kuppevelt TH, Masu M, Keino-Masu K.

J Biol Chem. 2012 Mar 16;287(12):9579-90. doi: 10.1074/jbc.M111.290262.

15.

Heparan sulfate sulfatase SULF2 regulates PDGFRα signaling and growth in human and mouse malignant glioma.

Phillips JJ, Huillard E, Robinson AE, Ward A, Lum DH, Polley MY, Rosen SD, Rowitch DH, Werb Z.

J Clin Invest. 2012 Mar;122(3):911-22. doi: 10.1172/JCI58215.

16.

Modifications of glycans: biological significance and therapeutic opportunities.

Muthana SM, Campbell CT, Gildersleeve JC.

ACS Chem Biol. 2012 Jan 20;7(1):31-43. doi: 10.1021/cb2004466. Review.

17.

hSulf-1 gene exhibits anticancer efficacy through negatively regulating VEGFR-2 signaling in human cancers.

Ji W, Yang J, Wang D, Cao L, Tan W, Qian H, Sun B, Qian Q, Yin Z, Wu M, Su C.

PLoS One. 2011;6(8):e23274. doi: 10.1371/journal.pone.0023274.

18.

Sulfatase 1 and sulfatase 2 in hepatocellular carcinoma: associated signaling pathways, tumor phenotypes, and survival.

Yang JD, Sun Z, Hu C, Lai J, Dove R, Nakamura I, Lee JS, Thorgeirsson SS, Kang KJ, Chu IS, Roberts LR.

Genes Chromosomes Cancer. 2011 Feb;50(2):122-35. doi: 10.1002/gcc.20838.

19.

The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets.

Yang JD, Nakamura I, Roberts LR.

Semin Cancer Biol. 2011 Feb;21(1):35-43. doi: 10.1016/j.semcancer.2010.10.007. Review.

20.

The heparan sulfate motif (GlcNS6S-IdoA2S)3, common in heparin, has a strict topography and is involved in cell behavior and disease.

Smits NC, Kurup S, Rops AL, ten Dam GB, Massuger LF, Hafmans T, Turnbull JE, Spillmann D, Li JP, Kennel SJ, Wall JS, Shworak NW, Dekhuijzen PN, van der Vlag J, van Kuppevelt TH.

J Biol Chem. 2010 Dec 24;285(52):41143-51. doi: 10.1074/jbc.M110.153791.

Items per page

Supplemental Content

Support Center